10.00
-2.00
(-16.67%)
As of January 30 at 12:33:38 PM EST. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-837.18
-935.12
-1,105.25
-1,436.30
-1,145.26
Financing Cash Flow
807.25
941.89
1,113.72
1,490.79
1,058.04
End Cash Position
-23.31
21.09
10.05
4.07
2.26
Interest Paid Supplemental Data
9.38
9.49
2.88
2.39
13.62
Issuance of Capital Stock
68.40
23.06
24.71
99.29
--
Issuance of Debt
784.19
1,061.75
590.25
766.50
325.00
Repayment of Debt
--
-142.91
--
--
-43.00
Free Cash Flow
-837.18
-935.12
-1,105.25
-1,436.30
-1,145.26
6/30/2021 - 1/7/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MYMX Mymetics Corporation
0.0010
0.00%
EMMA Emmaus Life Sciences, Inc.
0.0163
0.00%
PKTX ProtoKinetix, Incorporated
0.0095
-5.00%
GSTC GlobeStar Therapeutics Corporation
0.0003
0.00%
RGRX RegeneRx Biopharmaceuticals, Inc.
0.0014
0.00%
RSPI RespireRx Pharmaceuticals Inc.
0.0011
0.00%
EPRX Eupraxia Pharmaceuticals Inc.
2.8957
-3.48%
AXIM AXIM Biotechnologies, Inc.
0.0040
0.00%
TXTM ProText Mobility, Inc.
0.0009
0.00%
PVCT Provectus Biopharmaceuticals, Inc.
0.1071
-2.64%